Market Size of Spain Mammography Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 62.40 Million |
Market Size (2029) | USD 92.18 Million |
CAGR (2024 - 2029) | 8.12 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Spain Mammography Market Analysis
The Spain Mammography Market size is estimated at USD 62.40 million in 2024, and is expected to reach USD 92.18 million by 2029, growing at a CAGR of 8.12% during the forecast period (2024-2029).
- COVID-19 had an adverse effect on market growth during the initial phase of the pandemic. According to the study published in eLife in June 2022, there has been a huge reduction in breast cancer screening during the pandemic, especially in previous participants and newcomers. Furthermore, according to the study published in Cancer Journal in June 2021, breast cancer patients were the highest number of patients lost from diagnosis during the pandemic. Therefore, the impact of COVID-19 on breast screening attendance has led to a decline in the market growth initially. However, the market has attained its pace post-pandemic and is anticipated to grow significantly over the forecast period.
- The factors driving the market growth include the growing burden of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns, among others.
- According to the Spanish Network of Cancer Registries in November 2022, the incidence of breast cancer in women in Spain was found to be 34,750 in 2022, with an increase of 0.9% each year. Therefore, the rising incidence of breast cancer in Spain is anticipated to increase the demand for breast cancer diagnosis, driving market growth. Furthermore, the rising benefits of early detection of breast cancer in women with risk-based cancer screening are anticipated to propel the market growth. For instance, according to the study published in PLOS ONE in February 2022, the increasing benefits of risk-based breast cancer screening have led to increased adoption of mammography.
- Therefore, the rising incidence and increasing benefits of early detection of breast cancers are anticipated to drive market growth. However, the risk of adverse effects from radiation exposure and lack of proper reimbursement for breast cancer diagnosis are expected to hinder the market growth.
Spain Mammography Industry Segmentation
As per the scope of the report, mammography is a standard diagnostic and screening technique used to screen breast tissues to check the presence of a malignant tumor. The process involves the usage of low-frequency X-rays to locate tumors in the breast.
The Spain mammography market is segmented by product type (digital systems, analog systems, breast tomosynthesis, and other product types) and end-user (hospitals, specialty clinics, and diagnostic centers).
The report offers the value (in USD) for the above segments.
By Product Type | |
Digital Systems | |
Analog Systems | |
Breast Tomosynthesis | |
Other Product Types |
By End-User | |
Hospitals | |
Specialty Clinics | |
Diagnostic Centers |
Spain Mammography Market Size Summary
The Spain mammography market is poised for significant growth over the forecast period, driven by an increasing incidence of breast cancer and advancements in breast imaging technology. The market experienced a temporary setback due to the COVID-19 pandemic, which led to a decline in breast cancer screening attendance. However, the market has rebounded and is expected to expand steadily, supported by investments in breast cancer screening campaigns and the rising benefits of early detection through risk-based screening. The market's growth is further bolstered by strategic initiatives from key players, such as partnerships and technological innovations, including the integration of artificial intelligence in mammography.
The market landscape is moderately competitive, with major players like GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers AG, Carestream Health Inc., and Koninklijke Philips NV actively participating. These companies are involved in various initiatives, such as product launches and collaborations, to enhance their market presence. The approval of new technologies and contrast agents by the European Union is expected to further drive segment growth. Additionally, the increasing awareness and demand for breast cancer screening in Spain, coupled with improved healthcare infrastructure, are anticipated to contribute to the market's expansion.
Spain Mammography Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Burden of Breast Cancer
-
1.2.2 Technological Advancements in the Field of Breast Imaging
-
1.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns
-
-
1.3 Market Restraints
-
1.3.1 Risk of Adverse Effects from Radiation Exposure
-
1.3.2 Lack of Proper Reimbursement for Breast Cancer Diagnosis
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD)
-
2.1 By Product Type
-
2.1.1 Digital Systems
-
2.1.2 Analog Systems
-
2.1.3 Breast Tomosynthesis
-
2.1.4 Other Product Types
-
-
2.2 By End-User
-
2.2.1 Hospitals
-
2.2.2 Specialty Clinics
-
2.2.3 Diagnostic Centers
-
-
Spain Mammography Market Size FAQs
How big is the Spain Mammography Market?
The Spain Mammography Market size is expected to reach USD 62.40 million in 2024 and grow at a CAGR of 8.12% to reach USD 92.18 million by 2029.
What is the current Spain Mammography Market size?
In 2024, the Spain Mammography Market size is expected to reach USD 62.40 million.